Clinical trial Recruiting at 1 site Interventional Ages 18 to 42 Women only

Is Day 3 vs Day 5-7 Assisted Hatching Helpful in IVF with PGT-A

Official title: The IMPACT Trial: Investigating Micro-Manipulation Procedures for Assisted Hatching Timing

Run by Reproductive Medicine Associates of New Jersey · NCT06377917 · Data updated 2026-11-12

This trial tests whether performing assisted hatching at Day 3 or at the blastocyst stage (Day 5-7) helps patients undergoing IVF with PGT-A to improve outcomes, using a within-patient split design.

Quick facts

Study typeInterventional
Ages18 Years to 42 Years
SexWomen only
Enrollment75 (estimated)
SponsorReproductive Medicine Associates of New Jersey
Academic / other
Locations1 site (Marlton, New Jersey)
StatusRecruiting
StartedMay 31, 2026
Main results expectedMay 31, 2027
Study endsMay 31, 2028
Registry record updatedJune 3, 2026
Trial IDNCT06377917 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Fertility patients undergoing an IVF cycle with plan for a single euploid embryo transfer, under age 42, with adequate ovarian reserve and BMI under 38, and two PN zygotes available for randomization.

Probably not a fit

Patients not responding to this approach or those not meeting eligibility criteria may see no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses a split-cohort design where each participant's fertilized embryos are randomized to either Day 3 cleavage-stage assisted hatching or sequential Day 5-7 blastocyst-stage hatching with TE biopsy. Each patient serves as her own control to reduce confounding. Laser-assisted hatching is the intervention under evaluation. Eligible participants are those undergoing an IVF cycle with plans for a single euploid embryo transfer after PGT-A, with specific age and ovarian reserve criteria, and BMI under 38. The study aims to determine the clinical significance of the different timing of assisted hatching in the context of euploid embryo transfer.

Why it matters

Potential benefit: If successful, this approach could improve embryo viability and improve chances of a successful euploid embryo transfer.

How similar studies have gone: Previous work has explored assisted hatching timing, but this specific split-cohort, within-patient randomization is relatively novel in the PGT-A context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for participants:

1. Patients undergoing an IVF cycle with plan for subsequent FET of a single euploid embryo
2. \<4 2PNs prior to randomization
3. Female partners age \<42 years old at start of VOR cycle
4. Normal ovarian reserve:

   1. AMH ≥ 1.2 ng/mL
   2. AFC ≥ 8
   3. FSH ≤ 12IU/L
5. BMI \<38
6. Patients who desire to transfer the best quality embryo for their embryo transfer.

Exclusion Criteria for participants:

1. All patients who do not voluntarily give their written consent for participation
2. Patients with a prior failed IVF cycle - defined as no blastocysts
3. Patients with a history of more than one failed euploid embryo transfer
4. Donor oocyte cycles
5. Gestational Carriers
6. Male partner with \<100,000 total motile spermatozoa per ejaculate (donor sperm is acceptable)
7. Use of surgical procedures to obtain sperm
8. Communicating hydrosalpinges without a plan for surgical correct prior to frozen embryo transfer
9. Endometrial Insufficiency, as defined by a prior cycle with maximal endometrial thickness \<6mm,), or persistent endometrial fluid
10. Single gene disorders, chromosomal translocations, or any other disorders requiring a more detailed embryo genetic analysis than standard PGT-A

Where it's running

  • Reproductive Medicine Associates of New Jersey
    Marlton, New Jersey, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.